Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus

Patricia Santiago-Munoz, Scott Roberts, Jeanne Sheffield, Barbara McElwee, George D. Wendel

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective: The purpose of this study was to evaluate the prevalence of hepatitis B and hepatitis C virus co-infection among pregnant women who are infected by human immunodeficiency virus and who attend an obstetric complications prenatal clinic. Study design: A de-identified research obstetric human immunodeficiency virus database was reviewed regarding patient demographic characteristics, risk factors for infection, history of sexually transmitted diseases, and initial CD4 count. Results: Four hundred fifty-five women who are infected with human immunodeficiency virus with 572 pregnancies were delivered over 11 years. The overall prevalence of human immunodeficiency virus and hepatitis B or C virus co-infection in our population was 6.3%. More specifically, 1.5% was co-infected with hepatitis B virus, and 4.9% was co-infected with hepatitis C virus. Patients with hepatitis virus were more likely to use intravenous drugs (52% vs 18%; P < .01) and alcohol (38% vs 5%; P < .01). Co-infected patients were older (28 vs 25.6 years; P = .04), but there were no racial differences. Median baseline CD4 counts in hepatitis B virus co-infected patients were significantly lower (310 cells/mm3) than those in either hepatitis C virus co-infected patients (453 cells/mm 3) or patients who were not co-infected with human immunodeficiency virus (414 cells/mm3). Conclusion: One of 16 pregnant women who were infected with human immunodeficiency virus was co-infected with hepatitis B or hepatitis C virus. Hepatitis B co-infections appear to be associated with more compromised immune status in our cohort.

Original languageEnglish (US)
Pages (from-to)1270-1273
Number of pages4
JournalAmerican Journal of Obstetrics and Gynecology
Volume193
Issue number3 SUPPL.
DOIs
StatePublished - Sep 2005

Fingerprint

Hepatitis C
Hepatitis B
Pregnant Women
Hepacivirus
HIV
Coinfection
Hepatitis B virus
Virus Diseases
CD4 Lymphocyte Count
Obstetrics
Hepatitis Viruses
Sexually Transmitted Diseases
Alcohols
Demography
Databases
Pregnancy
Infection
Research
Pharmaceutical Preparations
Population

Keywords

  • Co-infection
  • Hepatitis B virus
  • Hepatitis C virus
  • Human immunodeficiency virus
  • Pregnancy

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus. / Santiago-Munoz, Patricia; Roberts, Scott; Sheffield, Jeanne; McElwee, Barbara; Wendel, George D.

In: American Journal of Obstetrics and Gynecology, Vol. 193, No. 3 SUPPL., 09.2005, p. 1270-1273.

Research output: Contribution to journalArticle

@article{1026673d1a6a44b294e778bb0ff21994,
title = "Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus",
abstract = "Objective: The purpose of this study was to evaluate the prevalence of hepatitis B and hepatitis C virus co-infection among pregnant women who are infected by human immunodeficiency virus and who attend an obstetric complications prenatal clinic. Study design: A de-identified research obstetric human immunodeficiency virus database was reviewed regarding patient demographic characteristics, risk factors for infection, history of sexually transmitted diseases, and initial CD4 count. Results: Four hundred fifty-five women who are infected with human immunodeficiency virus with 572 pregnancies were delivered over 11 years. The overall prevalence of human immunodeficiency virus and hepatitis B or C virus co-infection in our population was 6.3{\%}. More specifically, 1.5{\%} was co-infected with hepatitis B virus, and 4.9{\%} was co-infected with hepatitis C virus. Patients with hepatitis virus were more likely to use intravenous drugs (52{\%} vs 18{\%}; P < .01) and alcohol (38{\%} vs 5{\%}; P < .01). Co-infected patients were older (28 vs 25.6 years; P = .04), but there were no racial differences. Median baseline CD4 counts in hepatitis B virus co-infected patients were significantly lower (310 cells/mm3) than those in either hepatitis C virus co-infected patients (453 cells/mm 3) or patients who were not co-infected with human immunodeficiency virus (414 cells/mm3). Conclusion: One of 16 pregnant women who were infected with human immunodeficiency virus was co-infected with hepatitis B or hepatitis C virus. Hepatitis B co-infections appear to be associated with more compromised immune status in our cohort.",
keywords = "Co-infection, Hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus, Pregnancy",
author = "Patricia Santiago-Munoz and Scott Roberts and Jeanne Sheffield and Barbara McElwee and Wendel, {George D.}",
year = "2005",
month = "9",
doi = "10.1016/j.ajog.2005.07.002",
language = "English (US)",
volume = "193",
pages = "1270--1273",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus

AU - Santiago-Munoz, Patricia

AU - Roberts, Scott

AU - Sheffield, Jeanne

AU - McElwee, Barbara

AU - Wendel, George D.

PY - 2005/9

Y1 - 2005/9

N2 - Objective: The purpose of this study was to evaluate the prevalence of hepatitis B and hepatitis C virus co-infection among pregnant women who are infected by human immunodeficiency virus and who attend an obstetric complications prenatal clinic. Study design: A de-identified research obstetric human immunodeficiency virus database was reviewed regarding patient demographic characteristics, risk factors for infection, history of sexually transmitted diseases, and initial CD4 count. Results: Four hundred fifty-five women who are infected with human immunodeficiency virus with 572 pregnancies were delivered over 11 years. The overall prevalence of human immunodeficiency virus and hepatitis B or C virus co-infection in our population was 6.3%. More specifically, 1.5% was co-infected with hepatitis B virus, and 4.9% was co-infected with hepatitis C virus. Patients with hepatitis virus were more likely to use intravenous drugs (52% vs 18%; P < .01) and alcohol (38% vs 5%; P < .01). Co-infected patients were older (28 vs 25.6 years; P = .04), but there were no racial differences. Median baseline CD4 counts in hepatitis B virus co-infected patients were significantly lower (310 cells/mm3) than those in either hepatitis C virus co-infected patients (453 cells/mm 3) or patients who were not co-infected with human immunodeficiency virus (414 cells/mm3). Conclusion: One of 16 pregnant women who were infected with human immunodeficiency virus was co-infected with hepatitis B or hepatitis C virus. Hepatitis B co-infections appear to be associated with more compromised immune status in our cohort.

AB - Objective: The purpose of this study was to evaluate the prevalence of hepatitis B and hepatitis C virus co-infection among pregnant women who are infected by human immunodeficiency virus and who attend an obstetric complications prenatal clinic. Study design: A de-identified research obstetric human immunodeficiency virus database was reviewed regarding patient demographic characteristics, risk factors for infection, history of sexually transmitted diseases, and initial CD4 count. Results: Four hundred fifty-five women who are infected with human immunodeficiency virus with 572 pregnancies were delivered over 11 years. The overall prevalence of human immunodeficiency virus and hepatitis B or C virus co-infection in our population was 6.3%. More specifically, 1.5% was co-infected with hepatitis B virus, and 4.9% was co-infected with hepatitis C virus. Patients with hepatitis virus were more likely to use intravenous drugs (52% vs 18%; P < .01) and alcohol (38% vs 5%; P < .01). Co-infected patients were older (28 vs 25.6 years; P = .04), but there were no racial differences. Median baseline CD4 counts in hepatitis B virus co-infected patients were significantly lower (310 cells/mm3) than those in either hepatitis C virus co-infected patients (453 cells/mm 3) or patients who were not co-infected with human immunodeficiency virus (414 cells/mm3). Conclusion: One of 16 pregnant women who were infected with human immunodeficiency virus was co-infected with hepatitis B or hepatitis C virus. Hepatitis B co-infections appear to be associated with more compromised immune status in our cohort.

KW - Co-infection

KW - Hepatitis B virus

KW - Hepatitis C virus

KW - Human immunodeficiency virus

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=24644498524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644498524&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2005.07.002

DO - 10.1016/j.ajog.2005.07.002

M3 - Article

C2 - 16157150

AN - SCOPUS:24644498524

VL - 193

SP - 1270

EP - 1273

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3 SUPPL.

ER -